loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Certificates of Suitability (CEPs) for cep_2022_117___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. Hyderabad IN (1)

filter

01 Naphazoline Hydrochloride (1)

filter

01 India (1)

filter

01 Valid (1)

Looking for Certificates of Suitability (CEPs) for CEP 2022-117 - Rev 00 of Biophore India Pharmaceuticals Pvt. Ltd. Hyderabad In

Looking for Certificates of Suitability (CEPs) for CEP 2022-117 - Rev 00 of Biophore India Pharmaceuticals Pvt. Ltd. Hyderabad In 1

20

Biophore India Pharmaceuticals Pvt. Ltd. Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.

They are recognized for Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

One of their significant offerings is Naphazoline Hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-117 - Rev 00

This Chemical Type CEP, issued on November 27, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 730 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY